肺结核与肺癌相互影响的研究进展

doi:10.11904/j.issn.1002-3070.2018.04.011

Abstract

Abstract: Both tuberculosis and lung cancer are seriously damaging to human health.Tuberculosis is currently at high morbidity and mortality,and lung cancer is one of the most common malignant tumors in the world.The prognosis of two diseases is different,but the causes of two diseases are mutual influence.The chronic inflammatory stimulation of tuberculosis,the phosphatase components of mycobacterium tuberculosis and the immune response induced by mycobacterium tuberculosis infection can cause lung cancer.Inappropriate treatment after lung cancer can also contribute to the growth of mycobacterium tuberculosis.Faced with such a global major public health problem,the epidemiological investigations and experimental results are used to clarify the reasons for the coexistence of two diseases in recent years.The evidence will provide a basis for the treatment of patients with tuberculosis and lung cancer.

Key words: Tuberculosis, Lung cancer, Mycobacterium tuberculosis

CLC Number:

R378.91

WEI Jing,TAO Yuanmeihui,FU Yingmei,ZHAO Jizi,ZHANG Wenli,ZHANG Fengmin. Research progress in the interaction between pulmonary tuberculosis and lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 340-343.

References

1 Bañuls AL,Sanou A,Anh NT,et al.Mycobacterium tuberculosis:ecology and evolution of a human bacterium[J].J Med Microbiol,2015,64(11):1261-1269.
2 Teixeira de Siqueira-Filha N,Militao de Albuquerque MF,Cunha Rodrigues L,et al.Economic burden of HIV and TB/HIV coinfection in a middle-income country:a costing analysis alongside a pragmatic clinical trial in Brazil[J].Sex Transm Infect,2018[Epub ahead of print].
3 Paleiron N,Bylicki O,André M,et al.Targeted therapy for localized non-small-cell lung cancer:a review[J].Oncol Targets Ther,2016,9:4099-4104.
4 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
5 Everatt R,Kuzmickiene I,Davidaviciene E,et al.Incidence of lung cancer among patients with tuberculosis:a nationwide cohort study in Lithuania[J].Int J Tuberc Lung Dis,2016,20(6):757-763.
6 史清明.肺结核合并肺癌汇集分析[C].桂林:中国防痨协会全国学术会议,2011:4.
7 Evman S,Baysungur V,Alpay L,et al.Management and surgical outcomes of concurrent tuberculosis and lung cancer[J].Thorac Cardiovasc Surg NLM,2016,65(7):542-545.
8 Zhou Y,Cui Z,Xiao Z,et al.The presence of old pulmonary tuberculosis is an independent prognostic factor for squamous cell lung cancer survival[J].J Cardiothoracic Surg,2013,8(1):123-123.
9 Hong S,Mok Y,Jeon C,et al.Tuberculosis,smoking and risk for lung cancer incidence and mortality[J].Int J Cancer,2016,139(11):2447-2455.
10 Wang YH,Shen XD.Human immunodeficiency virus infection and mortality risk among lung cancer patients:A systematic review and meta-analysis[J].Medicine(Baltimore),2018,97(15):e0361.
11 Fujita T,Endo M,Gu Y,et al.Mycobacterium tuberculosis infection in cancer patients at a tertiary care cancer center in Japan[J].J Infect Chemother,2014,20(3):213-216.
12 Yu YH,Liao CC,Hsu WH,et al.Increased lung cancer risk among patients with pulmonary tuberculosis:a population cohort study[J].J Thorac Oncol,2011,6(1):32-37.
13 Fan WC,Ting WY,Lee MC,et al.Latent TB infection in newly diagnosed lung cancer patients-A multicenter prospective observational study[J].Lung Cancer,2014,85(3):472-478.
14 Leung CC.Does tuberculosis increase the risk of lung cancer?[J].Int J Tuberc Lung Dis,2016,20(6):712.
15 周媛.肺结核合并肺癌的病变部位、肺癌的病理分型、肺癌与肺结核之间的关系探讨[J].中国医药指南,2017,15(29):144-145.
16 Simonsen DF,Farkas DK,S?gaard M,et al.Tuberculosis and risk of cancer:a Danish nationwide cohort study[J].Int J Tuberc Lung Dis,2014,18(10):1211-1219.
17 Wang J,Ge P,Qiang L,et al.The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation[J].Nature Communications,2017,8(1):244-260.
18 Pichugin AV,Yan BS,Sloutsky A,et al.Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts[J].Am J Pathol,2009,174(6):2190-2201.
19 Nalbandian A,Yan BS,Pichugin A,et al.Lung carcinogenesis induced by chronic tuberculosis infection:the experimental model and genetic control[J].Oncogene,2009,28(17):1928-1938.
20 Dehai C,Bo P,Qiang T,et al.Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6[J].Immunology Letters,2014,160(1):1-10.
21 Gupta PK,Tripathi D,Kulkarni S,et al.Mycobacterium tuberculosis H37Rv infected THP-1 cells induce epithelial mesenchymal transition(EMT)in lung adenocarcinoma epithelial cell line(A549)[J].Cell Immunol,2016,300:33-40.
22 Holla S,Ghorpade DS,Singh V,et al.Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis[J].Molecular Cancer,2014,13(1):210-223.
23 Jensen KH,Persson G,Bondgaard AL,et al.Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer[J].Acta Oncol,2018,31:1-2.
24 Zhou Y,Hu Z,Cao S,et al.Concomitant mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development[J].Oncology Reports,2017,38(2):685-692.
25 Tamura A.Tuberculosis and lung cancer[J].Kekkaku Tuberculosis,2016,91(1):17-25.
26 Wu MF,Jian ZH,Huang JY,et al.Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD[J].BMC Cancer,2016,16(1):778-785.
27 Tian Y,Hao T,Cao B,et al.Clinical end-points associated with mycobacterium tuberculosis and lung cancer:implications into host-pathogen interaction and coevolution[J].Biomed Res Int,2015,2015:827829.
28 Simonsen DF,Farkas DK,Horsburgh CR,et al.Increased risk of active tuberculosis after cancer diagnosis[J].J Infect,2017,74(6):590-598.
29 Suzuki Y,Imokawa S,Sato J,et al.Cumulative incidence of tuberculosis in lung cancer patients in Japan:A 6-year observational study[J].Respir Investig,2016,54(3):179-183.
30 ?akar B,?ileda? A.Evaluation of coexistence of cancer and active tuberculosis:16 case series[J].Respir Med Case Rep,2017,23:33-37.
31 Jacobs RE,Gu P,Chachoua A.Reactivation of pulmonary tuberculosis during cancer treatment[J].Int J Mycobacteriol,2015,4(4):337-340.
32 Fijo?ek J,Wiatr E,Polubiec-Kownacka M,et al.Pulmonary tuberculosis mimicking lung cancer progression after 10 years of cancer remission[J].Adv Respir Med,2018,86(2):92-96.
33 Lee HY,Jin WK,Chang DY.A case of tuberculosis reactivation suspected of cancer progression during oral tyrosine kinase inhibitor treatment in a patient diagnosed as non-small cell lung cancer[J].J Thorac Dis,2017,9(8):1-5.
34 Hwang IK,Paik SS,Lee SH.Impact of pulmonary tuberculosis on the EGFR mutationalstatus and clinical outcome in patients with lung adenocarcinoma[J].Cancer Res Treat,2018[Epub abead of print].
35 Halleux CM,Falzon D,Merle C,et al.The World Health Organization global aDSM database:generating evidence on the safety of new treatment regimens for drug-resistant tuberculosis[J].Eur Respir J,2018,51(3):1701643.
36 Zarredar H,Ansarin K,Baradaran B,et al.Potential molecular targets in the treatment of lung cancer using siRNA technology[J].Cancer Invest,2018,36(1):37-58.

[1]	ZHANG Jiawen,YU Yan,ZHANG Wei,CAO Jingyan,LUO Wen,SHANG Lihua. Serum metabolomics of small cell lung cancer patients based on UPLC-TOF/MS [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 200-205.
[2]	LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.
[3]	ZHANG Yanqiu,HAN Ameng,LI Jinwang,GU Tao,FU Zhanzhao,MAO Yu,ZHANG Zijian,YANG Zhen. The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 256-260.
[4]	ZHAO Su, ZHENG Xiaoyu, ZHU Kaibin, BU Jianlong, XU Shidong. Effect of complete lung cancer resection on the balance of Th17/Treg in the peripheral blood of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 142-148.
[5]	HU Zhihui, ZHANG Jing. Research progress in the prediction of SNP on radiation-induced lung injury [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 87-91.
[6]	MULALI Dina, HU Xin, TUOHAYI Jiazina. The application and prospect of telemedicine in lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 555-557.
[7]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[8]	CAI Jing, HOU Yue. The expression and clinical significance of serum miR-195 in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 415-419.
[9]	ZHONG Xuelai, YANG Haili, WANG Guonian. Effects of different anesthesia methods on postoperative cognitive function in elderly patients with lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 432-436.
[10]	ZHU Xiaoyun, ZHANG Yaning, LIN Fei, MA Biping. Analysis of lung cancer incidence and mortality in Jinshan District of Shanghai from 2002 to 2013 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 437-441.
[11]	CUI Xiaoyan,TU Qing,GAN Jianhui. Comparison between nalbuphine and oxycodone applied for patient controlled analgesia on postoperative immunological factor levels in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 309-314.
[12]	LEI Junhua, XU Guanhua, ZENG Jiangzheng, HUANG Fen, HE Zhihui, LU Yanda. Research on JAK3/STAT3 mechanism of non-small cell lung cancer NCI-H1975 cells treated with cryptotanshinone combined with cisplatin [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 198-202.
[13]	WAN Jingxuan, LI Honghong, ZHOU Xiangxiang, Ma Lin. Analysis for risk factors of pulmonary thromboembolism in the stage Ⅳ of lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 214-244.
[14]	ZHAI Keke, GAO Yuanyuan, FENG Xiao, XU Jingwen, GONG Yufang, MENG Qingwei. Analysis of first-line NSCLC chemotherapy in the phase Ⅳ patients with distant metastasis and first diagnosis after postoperative adjuvant chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 107-111.
[15]	DU Yesheng, HU Songliu, XU Xiangying. Study of oligodendrocyte metastasis in non-small cell lung cancer by stereotactic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 154-158.

Research progress in the interaction between pulmonary tuberculosis and lung cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments